Preconception genetic counseling

Clinical Obstetrics and Gynecology

Volumn 39, Issue 4, 1996, Pages 751-762

  Hogge, Joan S ^a   Allen Hogge, W ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; BETA CAROTENE; BETA N ACETYLHEXOSAMINIDASE A; COCAINE; CORTICOSTEROID; FIBROBLAST GROWTH FACTOR; FOLIC ACID; GLUCOSE; HYDANTOIN DERIVATIVE; ISOTRETINOIN; LITHIUM; PHENYLALANINE; RETINOL; RETINOL DERIVATIVE; VALPROIC ACID;

BIRTH DEFECT; ETHNIC GROUP; FAMILY HISTORY; FRAGILE X SYNDROME; GENETIC COUNSELING; GENETIC DISORDER; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MATERNAL DISEASE; MENTAL DEFICIENCY; NEURAL TUBE DEFECT; PEDIGREE; PHENYLKETONURIA; PRENATAL DIAGNOSIS; REVIEW; SPONTANEOUS ABORTION; TAY SACHS DISEASE;

ABNORMALITIES; FEMALE; GENETIC COUNSELING; GENETIC DISEASES, INBORN; GENETIC SCREENING; HUMANS; MEDICAL HISTORY TAKING; PATIENT SELECTION; PEDIGREE; PRECONCEPTION CARE; PREGNANCY; QUESTIONNAIRES;

EID: 10544227298     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199612000-00004     Document Type: Review

References (21)

1. Portnoi M-F, Joye N, van den Akker J, et al. Karyotype of 1142 couples with recurrent abortion. Obstet Gynecol. 1988;72:31-34.
2. Shaing R, Thompson L, Zhu Y, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 1994;78:335-342.
3. Pang S, Pollack MS, Marshall RN, Imken L. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Eng J Med. 1990;322:111-115.
4. Doksum T, Bernhardt BA. Population-based carrier screening for cystic fibrosis. Clin Obstet Gynecol. In press.
5. Finucane B. Should all pregnant women be offered carrier testing for fragile X syndrome? Clin Obstet Gynecol. In press.
6. Kitzmiller JL, Gavin LA, Gin GD, et al. Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA. 1991;265:731-736.
7. Drogari E, Smith I, Bensley M, Lloyd JK. Timing of strict diet in relation to fetal damage in maternal phenylketonuria. Lancet. 1987;2:927-930.
8. Platt LD, Koch R, Azen C, et al. Maternal phenylketonuria collaborative study, obstetric aspects and outcomes: the first 6 years. Am J Obstet Gynecol. 1992;166: 1150-1162.
9. Hanson JW, Myrianthopoulos NC, Harvey MAS, et al. Risks to the offspring of women treated with hydantoin anticonvulsants with emphasis on the fetal hydantoin syndrome. J Pediatr. 1976;89:662.
10. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med. 1991;324:674-677.
11. Jacobson SJ, Jones K, Johnson K, et al. Prospective multicenter study of pregnancy outcome after lithium exposure during the first trimester. Lancet. 1992;339:530-533.
12. National Institute on Drug Abuse. US Department of Health and Human Services. Washington, DC: Government Printing Office 1991; Publication No. ADM 91-1732.
13. Johnson SF, McCarter RJ, Ferenez C. Changes in alcohol, cigarettes and recreational drug use during pregnancy: implication for intervention. Am J Epidemiol. 1987;126:695-702.
14. Alcohol and the fetus - Is zero the only option? Editorial. Lancet. 1983;1:682-683.
15. Chavez GF, Mullinare J, Cordero JF. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA. 1983;262:795-798.
16. Little BB, Snell LM, Klein VR, Gilstrap LC. Cocaine abuse during pregnacny: maternal and fetal complications. Obstet Gynecol. 1989;73:157-160.
17. Stewart ML, McDonald JT, Levy AS, et al. Vitamin/mineral supplement use: a telephone survey of adults in the United States. J Am Diet Assoc. 1985;85:1585-1590.
18. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-137.
19. Milunsky A, Jick H, Jick S, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989;262:2847-2852.
20. Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832-1835.
21. Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995;333:1369-1373.